Listen to The Lancet: 04 January
Gerd Burmester and Richard Lane discuss a potential new treatment for refractory rheumatoid arthritis. (Source: Listen to The Lancet)
Source: Listen to The Lancet - January 4, 2013 Category: Journals (General) Authors: The Lancet Source Type: podcasts
The Lancet: January 04, 2013
Gerd Burmester and Richard Lane discuss a potential new treatment for refractory rheumatoid arthritis. (Source: Listen to The Lancet)
Source: Listen to The Lancet - January 4, 2013 Category: Journals (General) Authors: The Lancet Source Type: podcasts
Rheumatoid Arthritis: New Class, New Approval, New Approach
A look at how the pharmacotherapeutic management of RA is evolving. (Source: Medscape Rheumatology Podcast)
Source: Medscape Rheumatology Podcast - November 29, 2012 Category: Rheumatology Authors: Medscape Source Type: podcasts
Tofacitinib Approved: Now How Do We Use It?
Dr. Jonathan Kay discusses the potential role of the recently approved oral kinase inhibitor tofacitinib for rheumatoid arthritis. (Source: Medscape Rheumatology Podcast)
Source: Medscape Rheumatology Podcast - November 28, 2012 Category: Rheumatology Authors: Medscape Source Type: podcasts
" Disease Detective " -- The Discovery Files
Johns Hopkins researchers have created a synthetic protein that, when activated by ultraviolet light, can guide doctors to places within the body where cancer, arthritis and other serious medical disorders can be detected. (Source: The Discovery Files)
Source: The Discovery Files - September 27, 2012 Category: Science Authors: National Science Foundation Source Type: podcasts
Docs and Collective Bargaining: Has the ACA Opened a Door?
In his latest commentary, Bob Morrow talks about why the Affordable Care Act may provide an opening for physicians to organize for a greater voice in how they are paid. (Source: Medscape Rheumatology Podcast)
Source: Medscape Rheumatology Podcast - September 20, 2012 Category: Rheumatology Authors: Medscape Source Type: podcasts
Why Hospital Workers Should Be Forced to Get Flu Shots
Many people say that it's an individual's right to get or not get a flu shot, but bioethicist Arthur Caplan, PhD, says that getting the shot should be a condition of employment for providers. (Source: Medscape Rheumatology Podcast)
Source: Medscape Rheumatology Podcast - September 13, 2012 Category: Rheumatology Authors: Medscape Source Type: podcasts
Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Biologic Therapy: A Meta-analysis
Interview with Maria E Suarez-Almazor, MD, PhD, author of Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Biologic Therapy: A Meta-analysis (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - September 4, 2012 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
JAMA 2012-09-05, Vol. 308, No. 9, Author Interview
Interview with Maria E Suarez-Almazor, MD, PhD, author of Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Biologic Therapy: A Meta-analysis (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - September 4, 2012 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
Medicaid: Is Greater Access Worth It?
Given the Supreme Court's ACA ruling that will allow states to expand Medicaid coverage, the issue remains: Does greater access do good or harm -- and at what cost? Dr. Kathy Miller looks at a study that may provide answers. (Source: Medscape Rheumatology Podcast)
Source: Medscape Rheumatology Podcast - July 6, 2012 Category: Rheumatology Authors: Medscape Source Type: podcasts
A Welcome Oral for Rheumatoid Arthritis
Dr. Jonathan Kay discusses a new first-in-class agent for rheumatoid arthritis recently recommended for approval by an FDA advisory panel. (Source: Medscape Rheumatology Podcast)
Source: Medscape Rheumatology Podcast - July 6, 2012 Category: Rheumatology Authors: Medscape Source Type: podcasts
